Indevus, Madaus AG deal

IDEV granted Madaus rights to market Sanctura XR, a once-daily formulation of trospium chloride, in all territories outside

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE